Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
A reference sequence for this emerging model organism will facilitate research on type 2 diabetes and the health effects of circadian rhythm disruption.
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Glial cells were once considered neurons’ supporting actors, but new methods and model organisms are revealing their true importance in brain function.
From determining structures to figuring out functions, brain-mapping scientists are applying new technologies to understand the hub of the central nervous system.